News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on AstiVita.
RELATED STOCKHEAD STORIES
Director Trades
Directors’ Trades: Which Malaysian Rich Listers spent over $38 million on their own ASX stock?
News
Hot Money Monday: Asian American Medical Group is the most in-demand stock on the ASX right now
Director Trades
Directors Trades: Falling share prices spur more big buys
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Bio-Gene reckons its spray kills mozzies dead; shares fly
Director Trades
Director Trades: Guess which prodigy bought 24pc of Astivita last week?
News
Another Lev Mizikovsky company made an ‘unexpected’ profit in January
News
You win one, lose one: Lev Mizikovsky’s other company doubled H1 profit
IPO Watch
IPO Watch: SenterpriSys reckons it’s solved all of builders’ problems with one software kit
Director Trades
